Mesothelin, a type of protein present on the surface of some
cells in the human body, can trigger mesothelioma and other types of cancer,
including ovarian, pancreatic and abdominal cancers. Given of the vague biological
purpose of this protein, it occurs that it is excessively present in certain types of
cancer cells that doctors would look to it for warning signs.
Cancer experts are assessing the part of mesothelin in hastening
the occurrence of cancer, as well as, its “potential usefulness” as a signal of
cancer for doctors who are trying to diagnose a patient’s disease, reports AboutMesothelioma.net.
While treatments are available for mesothelioma patients,
still, no known cure has been invented as of yet. In the U.S. alone, around 3,000
people are found to be suffering from malignant mesothelioma. That’s on a
yearly basis. The main cause is asbestos exposure at a workplace or during
military service.
An February 2013 article published by the journal
Anti-Cancer Agents in Medicinal Chemistry writes that medical researchers at
the National Cancer Institute in Bethesda, Maryland and East China Normal
University in Shanghai, agree that mesothelin has three main function in
advancing mesothelioma cancer:
Implantation—Mesothelin may aid in grafting tumors
in the abdominal cavity. This leads to peritoneal mesothelioma;
Survival—Mesothelin may have a significant
function in enabling the survival of mesothelioma cancer cells;
Resistance—Mesothelin may boost the resistance of
mesothelioma cancer cells against chemotherapy drugs.
With the vital role of mesothelin, researchers agree that
what is needed is a druge that could neutralize mesothelin’s function for more
effective mesothelioma treatment. This could lead to more effective
chemotherapy drugs.
Some antibody drugs that upset the operation of mesothelin still
under clinical studies for evaluation.
Additional research is needed to come up with a strong
conclusion with regards to the role of mesothelin in the growth and spread of
malignant tumors, cancer cell survival and drug resistance. The researchers
conclude that studies on mesothelin biology is very helpful in determining an effective
antibody therapy that would aim at mesothelin in solid tumors.
No comments:
Post a Comment